U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817108) titled 'Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above' on Sept. 08.
Brief Summary: The primary objective of this study is to evaluate the vaccine efficacy, safety and immunogenicity of 2 injections (approximately 2 months apart) of ABO1108 in adults aged 40 years or above.
Study Start Date: June 27
Study Type: INTERVENTIONAL
Condition:
Varicella-zoster Virus
Intervention:
BIOLOGICAL: ABO1108
Formulation for injection
DRUG: Placebo
0.9% sodium chloride (normal saline) injection
Recruitment Status: RECRUITING
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Published by HT Digital...